Cyclacel Pharmaceuticals Inc (CYCCP) Plans Quarterly Dividend of $0.15
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCCP) declared a quarterly dividend on Friday, September 15th, Wall Street Journal reports. Investors of record on Friday, October 13th will be given a dividend of 0.15 per share on Wednesday, November 1st. This represents a $0.60 dividend on an annualized basis and a yield of 10.26%. The ex-dividend date is Thursday, October 12th.
Cyclacel Pharmaceuticals (NASDAQ CYCCP) traded up 1.74% during trading on Friday, reaching $5.85. 840 shares of the company were exchanged. The firm’s 50 day moving average is $6.12 and its 200 day moving average is $6.38. The stock’s market capitalization is $66.69 million. Cyclacel Pharmaceuticals has a 52-week low of $5.05 and a 52-week high of $8.50.
COPYRIGHT VIOLATION NOTICE: This story was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/09/15/cyclacel-pharmaceuticals-inc-cyccp-plans-quarterly-dividend-of-0-15.html.
Cyclacel Pharmaceuticals Company Profile
Cyclacel Pharmaceuticals, Inc operates in the field of cell cycle biology. The Company has generated various families of anticancer drugs that act on the cell cycle, including nucleoside analogs, cyclin dependent kinase (CDK) inhibitors, polo-like kinase (PLK) inhibitors and Aurora Kinase/vascular endothelial growth factor receptor (AK/VEGFR) inhibitors.
Receive News & Ratings for Cyclacel Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyclacel Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.